Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1G93A) transgenic amyotrophic lateral sclerosis (ALS) mice

被引:8
|
作者
Lee, Jae Chul [1 ]
Jin, Younggeon [2 ,3 ]
Jin, Juyoun [2 ,3 ]
Kang, Bong Gu [2 ,3 ]
Nam, Do-Hyun [2 ,3 ]
Joo, Kyeung Min [1 ]
Cha, Choong Ik [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110799, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Amyotrophic lateral sclerosis; In vitro expansion; Mutant SOD1 transgenic mouse; Neural stem cell; Hippocampus; Primary culture; SUPEROXIDE-DISMUTASE; MOTOR-NEURONS; DISEASE; NEUROGENESIS; DEGENERATION; MODEL; PROLIFERATION; PROGRESSION; MICROGLIA; SURVIVAL;
D O I
10.1179/016164110X12807570509899
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: The aim of present study is to investigate more functional neural stem cells (NSCs) could be isolated from brains with amyotrophic lateral sclerosis (ALS) and expanded in vitro, based on previous reports demonstrating de novo neurogenesis is enhanced to replace degenerating neural tissue. Methods: Thirteen-or eighteen-week-old mutant human Cu/Zn superoxide dismutase (SOD1(G93A)) transgenic ALS and wild-type SOD1 transgenic control mice were utilized. Changes in numbers of NSCs in the dentate gyrus were analyzed by immunohistochemistry against nestin and CD133. NSCs were primarily cultured from hippocampus of ALS or control mice. Expression of NSC markers, in vitro expansion capacity, and differentiating potential were compared. Results: Hippocampus of 13-week-old pre-symptomatic ALS mice harbor more cells that can be propagated for more than 12 passages in vitro, compared with same age control mice. Primarily-cultured cells formed neurospheres in the NSC culture medium, expressed NSC markers, and differentiated into cells with differentiated neural cell characteristics in the differentiation condition confirming that they are NSCs. In contrast, long-term expansible NSCs could not be derived from brains of 18-week-old symptomatic ALS mice with the same experimental techniques, although they had comparable nestin-immunoreactive cells in the dentate gyrus. Discussion: These results would suggest that increased neuroregeneration in early phase of ALS could be translated to regenerative approaches; however, long-term exposure to ALS microenvironments could abolish functional capacities of NSCs.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 50 条
  • [21] Nuclear Localization of Human SOD1 and Mutant SOD1-Specific Disruption of Survival Motor Neuron Protein Complex in Transgenic Amyotrophic Lateral Sclerosis Mice
    Gertz, Barry
    Wong, Margaret
    Martin, Lee J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (02) : 162 - 177
  • [22] Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice
    Moreno-Martinez, Laura
    Gaja-Capdevila, Nuria
    Mosqueira-Martin, Laura
    Herrando-Grabulosa, Mireia
    Rodriguez-Gomez, Laura
    Gonzalez-Imaz, Klaudia
    Calvo, Ana C.
    Sagartzazu-Aizpurua, Maialen
    Moreno-Garcia, Leticia
    Fuentes, Jose Manuel
    Acevedo-Arozena, Abraham
    Aizpurua, Jesus Maria
    Miranda, Jose Ignacio
    Lopez de Munain, Adolfo
    Vallejo-Illarramendi, Ainara
    Navarro, Xavier
    Osta, Rosario
    Gil-Bea, Francisco Javier
    BRITISH JOURNAL OF PHARMACOLOGY, 2025,
  • [23] Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model
    Magota, Hirotoshi
    Sasaki, Masanori
    Kataoka-Sasaki, Yuko
    Oka, Shinichi
    Ukai, Ryo
    Kiyose, Ryo
    Onodera, Rie
    Kocsis, Jeffery D.
    Honmou, Osamu
    BRAIN RESEARCH, 2021, 1757
  • [24] Altered astrocytic response to activation in SOD1G93A mice and its implications on amyotrophic lateral sclerosis pathogenesis
    Benkler, Chen
    Ben-Zur, Tali
    Barhum, Yael
    Offen, Daniel
    GLIA, 2013, 61 (03) : 312 - 326
  • [25] SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis
    Park, Fijulien H.
    Elpers, Christiane
    Reunert, Janine
    McCormick, Michael L.
    Mohr, Julia
    Biskup, Saskia
    Schwartz, Oliver
    Rust, Stephan
    Grueneberg, Marianne
    Seelhoefer, Anja
    Schara, Ulrike
    Boltshauser, Eugen
    Spitz, Douglas R.
    Marquardt, Thorsten
    BRAIN, 2019, 142 : 2230 - 2237
  • [26] Neuroprotective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Riancho, Javier
    Ruiz-Soto, Maria
    Berciano, Maria T.
    Berciano, Jose
    Lafarga, Miguel
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [27] G93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis
    Cova, Emanuela
    Ghiroldi, Andrea
    Guareschi, Stefania
    Mazzini, Giuliano
    Gagliardi, Stella
    Davin, Annalisa
    Bianchi, Marika
    Ceroni, Mauro
    Cereda, Cristina
    CELLULAR SIGNALLING, 2010, 22 (10) : 1477 - 1484
  • [28] Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1G93A mutant mice
    Bakshi, Rachit
    Xu, Yuehang
    Mueller, Kaly A.
    Chen, Xiqun
    Granucci, Eric
    Paganoni, Sabrina
    Sadri-Vakili, Ghazaleh
    Schwarzschild, Michael A.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2018, 92 : 12 - 16
  • [29] Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival
    Kim, Ahwon
    Lee, Do-Yeon
    Sung, Jung-Joon
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (09) : 2908 - 2925
  • [30] Mass spectrometry imaging of SOD1 protein-metal complexes in SOD1G93A transgenic mice implicates demetalation with pathology
    Hale, Oliver J.
    Wells, Tyler R.
    Mead, Richard J.
    Cooper, Helen J.
    NATURE COMMUNICATIONS, 2024, 15 (01)